Intermittent Versus Continuous Erlotinib with Concomitant Modified “XELOX” (q3w) in First‐line Treatment of Metastatic Colorectal CancerB. Ma,S. L. Chan,W. M. Ho,A. Poon,E. P. Hui,R. D. Dattatray,S. C. C. Wong,A. T. C. ChanANNALS OF ONCOLOGY（2010）引用 7|浏览39暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
